JQ1 attenuates cMYC expression and suppresses cell proliferation, and thus, the effect of JQ1 treatment on Merkel cell carcinoma [47, 48], bladder cancer [49], oral squamous cell carcinoma [50], and hematologic malignancies [44, 51] in which cMYC is overexpressed has been reported. Here, MYC is linked to Merkel cell skin cancer.